特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
851242

動物用分子診断の世界市場 - 成長、動向、予測(2019年~2024年)

Veterinary Molecular Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 114 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
動物用分子診断の世界市場 - 成長、動向、予測(2019年~2024年)
出版日: 2020年08月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 114 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

畜産業の発展や、ペットの社会的地位の変化などにより、迅速で信頼性の高い診断技術に対するニーズが高まっています。米国では、2018年に人口の60%以上がペットを所有しているとの報告がされています。ペットを家族の一員として飼うペットの家族化の傾向の高まりによって動物医療の需要が高まっています。

当レポートでは、動物用分子診断の世界市場を調査し、市場の概要、製品・用途・技術・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
    • 動物疾患の罹患率の上昇
    • 動物由来タンパク質の需要増加
    • 動物の医療費支出の増加
  • 阻害要因
    • 熟練技能者の不足
    • 診断検査のコストの高さ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 製品別
    • 装置
    • キット・試薬
    • ソフトウェア・サービス
  • 用途別
    • 感染症
    • 遺伝学
    • その他
  • 技術別
    • PCR(ポリメラーゼ連鎖反応)
    • マイクロアレイ
    • DNAシーケンシング
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Biochek BV
    • Biomerieux SA
    • Bioneer Corporation
    • Idexx Laboratories Inc.
    • Ingenetix GmbH
    • Neogen Corporation
    • Thermo Fischer Scientific Inc.
    • Veterinary Molecular Diagnostics Inc.

第7章 市場機会および将来動向

目次
Product Code: 64809

The veterinary molecular diagnostics is primarily driven by the growing pet animal population around the globe, increased animal health spending and advancements in veterinary molecular diagnostics.

Developments in the animal farming sector and changing societal attitude toward pet animals have resulted in an increased demand for fast and reliable diagnostic techniques. Molecular diagnostics possess the potential to address this growing demand.

As of 2018, more than 60% of the US population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.

As per the estimates of the American Pet Products Association, the total American pet industry expenditure is expected to reach USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions.

Furthermore, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.

Key Market Trends

The Kits and Reagents Segment is Expected to Register Robust Growth During The Forecast Period

  • Majority of the commercial products in the global veterinary molecular diagnostics market are available in the form of kits. These kits are predominantly based on PCR techniques and help in the screening of a family of related disorders.
  • The kits based on microarrays are steadily increasing their market share. Over the forecast period, many products based on immune-assays are expected to receive marketing approval. There are several assays linked to pathogen and viruses detection, which are combined with the PCR techniques, such as Porcine Epidemic Diarrhea Virus (PEDv), Porcine Deltacoronavirus (PDCoV), and Transmissible Gastroenteritis Virus (TGEV).
  • Moreover, companies are involved in the development of the veterinary diagnostics kits and launching new products, this is likely to expand the segment growth. in September 2019, CEVA partners with Biotecon Diagnostics to introduce a real-time test kit to fight the growing problem of salmonella on pig farms
  • However, over the forecast period, the kits and reagent segment is poised to register rapid growth, due to the growing trend of performing tests at the large scale across multiple hospitals.

North America is Expected to Retain the Largest Share in the Market

North America veterinary molecular diagnostics market is projected to have the largest share over the forecast period. Additionally, the North American region is expected to exhibit the highest growth rate over the forecast period. This is primarily due to the increasing trend of pet ownership in the region and rising demand for animal-based proteins in the region. The United States is expected to retain its significant market share, owing to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries has been identified as the major factor fueling the market growth.

Competitive Landscape

The market players in veterinary molecular diagnostics are focusing on R&D and new product launches to expand their market share. The key market players include, Biomerieux SA, Ingenetix GmbH, Idexx Laboratories Inc., Neogen Corporation and Thermo Fischer Scientific Inc. among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Animal Diseases
    • 4.2.2 Increase in Demand for Animal-derived Proteins
    • 4.2.3 Growth in Animal Health Expenditure
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnel
    • 4.3.2 High Cost of Diagnostic Tests
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Kit and Reagents
    • 5.1.3 Software and Services
  • 5.2 By Application
    • 5.2.1 Infectious Diseases
    • 5.2.2 Genetics
    • 5.2.3 Other Applications
  • 5.3 By Technology
    • 5.3.1 PCR
    • 5.3.2 Microarray
    • 5.3.3 DNA Sequencing
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biochek BV
    • 6.1.2 Biomerieux SA
    • 6.1.3 Bioneer Corporation
    • 6.1.4 Idexx Laboratories Inc.
    • 6.1.5 Ingenetix GmbH
    • 6.1.6 Neogen Corporation
    • 6.1.7 Thermo Fischer Scientific Inc.
    • 6.1.8 Veterinary Molecular Diagnostics Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.